BAK1 gene variation and abdominal aortic aneurysms—results may have been prematurely overrated by Küry, Sébastien et al.
Human Mutation LETTER TO THE EDITORS
BAK1 Gene Variation and Abdominal Aortic
Aneurysms—Results May Have Been Prematurely
Overrated
Se ´bastien Ku ¨ry, Fabrice Airaud, Philippe Piloquet, and Ste ´phane Be ´zieau
CHU de Nantes, po ˆle de Biologie, service de Ge ´ne ´tique Me ´dicale, Nantes, cedex 1, France
Communicated by Garry R. Cutting
Received 30 October 2009; accepted revised manuscript 5 February 2010.
Published online 28 September 2010 in Wiley Online Library (wileyonlinelibrary.com). DOI 10.1002/humu.21324
We have read with much interest the article Gottlieb et al.
[2009] about BAK1 (MIM] 600516), as well as the epistolary
exchange with Dr. Hatchwell that followed [Gottlieb et al., 2010;
Hatchwell, 2010]. Our reading was all the more careful that the
message delivered by the authors was strong, and was largely
echoed and amplified in many scientific and nonscientific
journals. Much noise was made about this article presented as a
revolution in genetics, hanging a question mark over the dogma of
a unique genome shared by all body cells. We were therefore eager
to know all the details about this outstanding finding.
In the first place, we thought that it was quite an original idea to
simultaneously compare the genotypes of the BAK1 gene between
abdominal aortic tissue, matched nondiseased tissue, and blood
leukocytes. Yet, we were quickly annoyed by many inaccuracies and
unclear explanations that seemed to distort the authors’ message.
The most confusing point fits in the commentary on the article
by Hatchwell [2010]. We did not understand why the authors had
not compared the same type of nucleic acid between blood (DNA)
and matching aortic tissues (RNA). And yet, in their reply to
Dr. Hatchwell, the authors state that ‘‘blood and tissue BAK1
genomic sequences were identical’’ [Gottlieb et al., 2010]. It is
astounding that the authors forgot to mention this crucial
observation in their original article, because it runs counter to
the theory of a genome varying according to the tissue, that is, the
very message widely spread by the media. Indeed, this observation
means that the two different genotypes reported by Gottlieb et al. in
Table 2 of their article do not correspond to differences between
tissues but rather to differences between types of nucleic acid (DNA
vs. RNA). It therefore excludes the authors’ postulate of a mosaicism
and of an allelic selection due to some environmental conditions.
The alternative hypothetic mechanism of somatic mutations
seems also to be discarded. Indeed, Gottlieb et al.’s Table 2 suggests
that allelic variants at position 42 (rs1051911), 52 (rs1051912),
and 81 (rs1051913) are likely in very strong or even complete
linkage disequilibrium, because only two haplotype combinations
are represented (major haplotype CAG/GCT/ATC vs. variant
haplotype CAA/GCC/ATT). By the way, it is not clear whether the
genotypes reported in Gottlieb et al.’s Table 2 were found in a
homozygous state; it seems odd that the sequences of the aortic
tissues do not exhibit traces of the major allelic variants, which are
largely predominant in blood (of note, rs1051912 and rs1051913
variant alleles were never found in any of the HapMap or SNP500
cancer populations). Assuming that the genotypes are really
homozygous anyway, the results in Table 2 of Gottlieb et al.’s
article mean that all the aortic DNA samples tested would have to
derive from a primary DNA that would have systematically
undergone the same triple modification. To our knowledge, even
in cancer, where recurrent somatic mutations in hot spots are well
known (e.g., mutation V600E in BRAF or mutations in codons 12
and 13 of KRAS in colorectal cancer) [Oliveira et al., 2007], a
triple nucleotidic modification that would systematically affect
three distinct and nonadjacent codons has never been described.
The explanation of the difference between DNA and RNA
sequences observed by the authors must therefore lie at the RNA
level. Yet, it cannot be explained by RNA editing. The work of
Gottlieb et al. [2009] indeed highlights changes G4A (codon 42),
T4C (codon 52), and C4T (codon 81), whereas in the
mechanism of RNA editing described to date, ADARs and cytidine
deaminases induce A4G and C4T change, respectively [Mattick
and Mehler, 2008]. Thus, only the variant observed in codon 81,
that is, the one corresponding to a synonymous change, could be
affected by RNA editing, unless the authors point to a new
mechanism.
A more plausible hypothesis remains the crosscontamination
between BAK1 transcript and genomic DNA of pseudogene BAK2
(BAK1P1) suggested by Hatchwell [2010]. Gottlieb et al. [2010]
excluded that BAK1 cDNA sequences of abdominal aortic tissues
may have been contaminated by BAK2 sequences, because of the
RNAse treatment used for reverse transcription. They consider
thereby that BAK2 exists in its genomic form only [Gottlieb et al.,
2010]. However, according to the databank reference sequence
XM_002348050, BAK2 would have been predicted according to
similarities to 1 mRNA, 18 ESTs, and 5 proteins. The fact that one
supporting evidence is an mRNA suggests that an mRNA
transcript and even a translation is not unlikely for BAK2. This
would confirm the hypothesis of a sequencing artifact [Hatchwell,
2010], given that the RNA sequences of BAK1 and BAK2 differ
exactly at the points of variation (single nucleotide polymorph-
isms [SNPs]) observed by Gottlieb et al. [2009] (Fig. 1). Besides,
in order to refute the hypothesis of a contamination by a sequence
other than BAK1, the authors use two variants concerning codons
2 (ATG/GCC/TCG for BAK2 vs. ATG/GCT/TCG for BAK1) and
145 of both BAK1 and BAK2 that would enable to discriminate the
two genes [Gottlieb et al., 2010]. The problem is that the variant at
codon 2 is not present in all the BAK2 sequences of reference
found in the NCBI databank (Fig. 2), which makes very doubtful
the validity of the reference sequence for BAK2 and thus the
demonstration of Gottlieb et al. [2009, 2010]. Moreover, the
authors do not comment on the six other variants that differ
between the sequences of BAK1 (XM_002348050) and BAK2
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In conclusion, like Dr. Hatchwell, we are not convinced that the
cDNA sequence presented by Gottlieb et al. [2009, 2010] in the
aortic tissues corresponds to BAK1 and not to pseudogene BAK2.
Our doubts are all the more strong because the five controls tested
by the authors all carry the three rare variants rs1051911 (codon 42),
rs1051912 (codon 52), and rs105193 (codon 81). Whenever these
rare variants were truly predisposing to aneurysm, the probability
to find them in all five controls would be very low, unless there
had been a significant bias in the recruitment of the controls. Yet,
even if the contamination was confirmed there would still remain
one enigma: why would the authors find a homozygous variant
sequence, because the oligonucleotidic primers that they used for
their experiments perfectly match both BAK1 and BAK2 mRNA
sequences? One explanation could be an allele-specific amplifica-
tion due to an undescribed polymorphism in one of the primer
sequences.
All in all, Gottlieb et al. [2009] contains an accumulation of
inaccuracies and paradoxical results that put a doubt on their
conclusions. We do not pretend that their interpretations are
wrong, but we believe that there is too huge a contrast between the
strong message delivered by the authors and the quality of the
experiments and report that they proposed, which did not meet
the high-level standard expected for a major work—considering
also the obvious translation errors of original Table 2 of Gottlieb
et al.’s article corrected in the Erratum published online on 22
November 2009. Consequently, we hope that the authors will
extend their study in order to clarify the sequence variations.
It is also noteworthy that the quite neutral title of the article,
‘‘BAK1 gene variation and abdominal aortic aneurysms,’’ does not
reflect the revolutionary idea relayed by the media. This suggests
that the authors probably did not expect such an impact for their
work, and that their results might have been prematurely
overrated.
Figure 1. Comparison of BAK1 cDNA (NCBI reference: NM_001188.3) and BAK2 genomic sequences (NCBI reference: NG_000850). The
primers used by Gottlieb et al. [2009] for the RT-PCR of BAK1 are highlighted in blue. Sequences are numbered in base pairs using the same
nomenclature as Gottlieb et al. [2009]. The three nucleotides highlighted in red are the three SNPs found variant by the authors in their original
article, whereas the four remaining SNPs that they cited are highlighted in gray. The nucleotides highlighted in green are the two differences
between BAK1 and BAK2 cited by Gottlieb et al. [2010] in their reply to Hatchwell [2010] in order to justify the absence of amplification of BAK2.
The other differences between BAK1 and BAK2, which were not mentioned by Gottlieb et al., are highlighted in yellow.
Figure 2. Comparison of the different sequences retrieved from
NCBI for BAK2 gene. Focus on the two variants in codons 2 and 145
used by Gottlieb et al. [2010] to refute a crosscontamination between
BAK1 and BAK2 sequences. We show here that two of the five BAK2
reference sequences presented do not differ from BAK1 at codon 2.
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